Cheryl leads the country’s premier life sciences practice. She advises the industry’s largest investors and most innovative startups on highly complex transactions worldwide. With an international reputation for quality and helping clients advance their strategies, Cheryl combines deep knowledge of the market with a business-minded practical approach.
Cheryl is the leader of Torys’ Life Science practice, a cross-border group in both Canada and the United States. She represents the entire spectrum of biotech, medical device and health technology companies, from start-ups to large public companies, as well as venture capitalists, investment banks and academic medical centers.
Cheryl is widely recognized for her long track record of helping life sciences companies at all stages formulate and evolve their domestic and international growth strategies, source capital, and develop and optimize their corporate and tax structures. When clients need transactional counsel in the life sciences sector, Cheryl has extensive experience advising on venture and later-stage financings, IPOs, mergers and acquisitions, licensing transactions and joint ventures or alliances with strategic partners.
Cheryl has been named WXN’s Canada’s Top 100 Most Powerful Women four times and inducted into its Hall of Fame. She has been repeatedly recognized by LMG Life Sciences as the Canadian Finance & Corporate Attorney of the Year.
Prior to joining Torys, Cheryl led the 85-attorney life sciences group of a U.S. law firm.
‘Whip-smart ’ Cheryl Reicin is known for her ‘good grasp of the ecosystem’ and ‘deep connections,’ as well as her ability to ‘see the big picture and solve the right problems.’
2017-2022 | Chambers Canada—Leading lawyer in life sciences: corporate/commercial |
2021, 2019 | LMG Life Sciences—Canadian Finance & Corporate Attorney of the Year |
2012-2020 | LMG Life Sciences—Life Sciences Star in financial & corporate |
2010-2022 | Best Lawyers in Canada—Leading lawyer in biotechnology law and cannabis law |
2008-2022 | The Canadian Legal Lexpert Directory—Repeatedly recommended in biotechnology, technology transactions and corporate mid-market; consistently recommended in life sciences & health |
2010-2022 | Who’s Who Legal—Leading lawyer in life sciences |
2014-2021 | Expert Guides’ Women in Business Law—Leading practitioner in life sciences |
2019-2020 | Expert Guides: Best of the Best—Leading lawyer in life sciences |
2019 | Women’s Executive Network (WXN)—Hall of Fame inductee |
2014, 2016, 2017, 2019 | Women’s Executive Network (WXN)—Canada’s Most Powerful Women: Top 100 Award |
2012-2016 | IAM Patent 1000: The World’s Leading IP Transactions—Leading lawyer globally |
2014 | Best Lawyers in Canada—Biotechnology Law Lawyer of the Year in Toronto |
2010-2014 | International Who’s Who of Life Sciences Lawyers—Leading lawyer in transactional law |
2013-2014 | Women of Influence—Canada’s Top 25 Women of Influence: No. 1 in Professional Services category |
2013 | LMG Life Sciences—Finance & Transactional Lawyer of the Year |
Cheryl is active in the life sciences industry, including serving as a director for the HarbourVest Canada Industry Board, Canadian Women in Life Science (Founder), The Hospital for Sick Children (Trustee), The Hospital for Sick Children Commercialization Advisory Board, The Hospital for Sick Children Finance and Audit Committee, The Hospital for Sick Children Research Institute Review Advisory Committee, SickKids Foundation, Director Emeritus, Institute for the Study of Aging (Business Advisory Board), Genesis, incubator for social entrepreneurship (Chair and Founder), W*I*T*H (Women Innovating Together in Health), York University Faculty of Science (Dean’s Special Advisory Board) and Canada-Israeli Cardiovascular Innovation Forum (Steering Committee).